Merck & Co Inc
LSE:0QAH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck & Co Inc
LSE:0QAH
|
US |
|
T
|
Travelers Companies Inc
LSE:0R03
|
US |
|
Toronto-Dominion Bank
TSX:TD
|
CA |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
XHAM:MOH
|
FR |
|
S
|
Sega Sammy Holdings Inc
SWB:RYU
|
JP |
|
Avolta AG
F:D2JA
|
CH |
|
MERLIN Properties SOCIMI SA
MAD:MRL
|
ES |
|
W.p. Carey Inc
NYSE:WPC
|
US |
|
N
|
Nucor Corp
DUS:NUO
|
US |
Intrinsic Value
Is 0QAH undervalued or overvalued?
See the intrinsic value estimate for
Merck & Co Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Merck Does
Merck & Co. is a global drug company that makes prescription medicines, vaccines, and animal health products. Its best-known business is developing and selling branded drugs for cancer, infectious disease, diabetes, and other serious conditions. It also sells vaccines and medicines used by veterinarians and livestock producers.
- Headquarters
- United States of America US
- Employees
- 75 000
- IPO date
- Jan 1, 1941
Merck & has a wide economic moat
Legal protection for Merck’s medicines prevents rivals from freely selling copies, allowing it to earn more than it could in a market filled with cheaper alternatives. Its protected treatments span cancer, vaccines and other diseases, so this protection extends beyond a single medicine.
Read the full moat analysis
Revenue & Expenses Breakdown
Merck & Co Inc
Earnings Waterfall
Merck & Co Inc
The intrinsic value for
Merck & Co Inc (0QAH) under the Base Case is hidden USD.
Compared with the current market price of 148.65 USD, the stock appears hidden.